A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer

Clinical trial NCT07740720 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07740720
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Rectal

Start date: 2026-09-17
Primary completion: 2029-12-12
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.